Case Report

Humoral Hypercalcemia of Malignancy with a Parathyroid Hormone-Related Peptide-Secreting Intrahepatic Cholangiocarcinoma Accompanied by a Gastric Cancer

Table 1

Laboratory data on admission.

WBC8900/μL
RBC476 × 104/μL
Hb15.9 g/dL
PLT21.7 × 104/μL
TP6.7 g/dL
Alb3.6 g/dL
T-Bil.0.6 mg/dL
D-Bil.0.2 mg/dL
ALP515 U/L
GOT64 U/L
GPT26 U/L
LDH190 U/L
Amy57 U/L
CPK27 U/L
UA10.0 mg/dL
BUN28.5 mg/dL
CRN1.27 mg/dL
Na138 mmol/L
K3.8 mmol/L
Cl98 mmol/L
Ca14.4 mg/dL
Corrected Ca14.8 mg/dL
I-P2.8 mg/dL
Mg1.7 mg/dL
CRP1.5 mg/dL
Glu129 mg/dL
CEA1.5 ng/mL (0.0~5.0)
CA19-96.2 U/mL (0.0~37.0)
AFP3.8 ng/mL (0.0~10.0)
HBs antigen(—)
HCV antibody(—)
PTH intact9 pg/mL (10~65)
PTHrP26.6 pmol/L (0~1.1)

Numbers in parentheses indicate the normal range; WBC: white blood cells; RBC: red blood cells; Hb: hemoglobin; PLT: platelets; TP: total protein; Alb: albumin; T-Bil.: total bilirubin; D-Bil.: direct bilirubin; ALP: alkaline phosphatase; GOT: glutamic oxaloacetic transaminase; GPT: glutamic pyruvic transaminase; LDH: lactate dehydrogenase; Amy: amylase; CPK: creatine phosphokinase; UA: uric acid; BUN: blood urea nitrogen; CRN: creatinine; Na: sodium; K: potassium; Cl: chlorine; Ca: calcium; I-P: inorganic phosphate; Mg: magnesium; CRP: C-reactive protein; Glu: glucose; CEA: carcinoembryonic antigen; CA: carbohydrate antigen; AFP: alpha fetoprotein; HBs: hepatitis B surface; HCV: hepatitis C virus; PTH: parathyroid hormone; PTHrP: parathyroid hormone-related peptide.